-
1
المؤلفون: J. Mazereeuw‐Hautier, A. Vahlquist, H. Traupe, A. Bygum, C. Amaro, M. Aldwin, A. Audouze, C. Bodemer, E. Bourrat, A. Diociaiuti, M. Dolenc‐Voljc, I. Dreyfus, M. El Hachem, J. Fischer, A. Gånemo, C. Gouveia, R. Gruber, S. Hadj‐Rabia, D. Hohl, N. Jonca, K. Ezzedine, D. Maier, R. Malhotra, M. Rodriguez, H. Ott, D.G. Paige, A. Pietrzak, F. Poot, M. Schmuth, J.C. Sitek, P. Steijlen, G. Wehr, M. Moreen, E.A. O'Toole, V. Oji, A. Hernandez‐Martin
المساهمون: MUMC+: MA Dermatologie (3), Dermatologie, MUMC+: MA AIOS Dermatologie (9), MUMC+: MA Dermatologie (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, CHU Toulouse [Toulouse], Uppsala University, Westfälische Wilhelms-Universität Münster = University of Münster (WWU), Odense University Hospital (OUH), Hospital de Santa Maria [Lisboa], Ichthyosis Support Group, PO Box 1242, Yateley, GU47 7FL, U.K., Association Ichtyose France, Bellerive sur Allier, France., CHU Necker - Enfants Malades [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Hopital Saint-Louis [AP-HP] (AP-HP), Bambino Gesù Children’s Hospital [Rome, Italy], University Medical Centre Ljubljana [Ljubljana, Slovenia] (UMCL), University of Freiburg [Freiburg], Skane University Hospital [Malmo], Lund University [Lund], Bern University Hospital [Berne] (Inselspital), University of Innsbruck, Centre Hospitalier Universitaire Vaudois [Lausanne] (CHUV), Unité différenciation épidermique et auto-immunité rhumatoïde (UDEAR), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM), Epidemiology in Dermatology and Evaluation in Therapeutics (EpiDermE), Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Iuliu Hatieganu University of Medicine & Pharmacy, Queen Victoria Hospital NHS Foundation Trust, Hospital Universitario Son Espases, Children's Hospital 'Auf der Bult', Royal Free Hospital [London, UK], Medical University of Lublin, Oslo University Hospital [Oslo], Maastricht University Medical Centre (MUMC), Maastricht University [Maastricht], University Hospitals Leuven [Leuven], Catholic University of Leuven - Katholieke Universiteit Leuven (KU Leuven), Queen Mary University of London (QMUL), University Hospital Münster - Universitaetsklinikum Muenster [Germany] (UKM), Hospital Infantil Universitario Niño Jesús (HIUNJ)
المصدر: Mazereeuw-Hautier, J, Vahlquist, A, Traupe, H, Bygum, A, Amaro, C, Aldwin, M, Audouze, A, Bodemer, C, Bourrat, E, Diociaiuti, A, Dolenc-Voljc, M, Dreyfus, I, El Hachem, M, Fischer, J, Gånemo, A, Gouveia, C, Gruber, R, Hadj-Rabia, S, Hohl, D, Jonca, N, Ezzedine, K, Maier, D, Malhotra, R, Rodriguez, M, Ott, H, Paige, D G, Pietrzak, A, Poot, F, Schmuth, M, Sitek, J C, Steijlen, P, Wehr, G, Moreen, M, O'Toole, E A, Oji, V & Hernandez-Martin, A 2019, ' Management of congenital ichthyoses : European guidelines of care, part one ', British Journal of Dermatology, vol. 180, no. 2, pp. 272-281 . https://doi.org/10.1111/bjd.17203
British Journal of Dermatology, 180(2), 272-281. Wiley
British Journal of Dermatology
British Journal of Dermatology, Wiley, 2019, 180 (2), pp.272-281. ⟨10.1111/bjd.17203⟩مصطلحات موضوعية: VITAMIN-D DEFICIENCY, PREMATURE EPIPHYSEAL CLOSURE, Consensus, MESH: Dermatology / methods, Administration, Topical, MESH: Social Support, ORAL RETINOID THERAPY, Administration, Oral, Genetic Counseling, Dermatology, MESH: Ichthyosiform Erythroderma, Congenital / psychology, 030207 dermatology & venereal diseases, 03 medical and health sciences, DOUBLE-BLIND, BONE CHANGES, 0302 clinical medicine, Behavior Therapy, QUALITY-OF-LIFE, MESH: Dermatologic Agents / therapeutic use, EPIDERMOLYTIC HYPERKERATOSIS, Humans, MESH: Consensus, [SDV.IMM.ALL]Life Sciences [q-bio]/Immunology/Allergology, KID SYNDROME, MESH: Humans, MESH: Behavior Therapy / standards, MESH: Behavior Therapy / methods, MESH: Ichthyosiform Erythroderma, Congenital / diagnosis, Social Support, MESH: Quality of Life, Ichthyosiform Erythroderma, Congenital, MESH: Dermatology / standards, MESH: Administration, Topical, Europe, HARLEQUIN ICHTHYOSIS, MESH: Genetic Counseling / standards, MESH: Ichthyosiform Erythroderma, Congenital / therapy, MESH: Administration, Oral, Quality of Life, [SDV.IMM]Life Sciences [q-bio]/Immunology, LAMELLAR ICHTHYOSIS, Dermatologic Agents, MESH: Europe, MESH: Systematic Reviews as Topic, [SDV.MHEP.DERM]Life Sciences [q-bio]/Human health and pathology/Dermatology, Systematic Reviews as Topic
وصف الملف: application/pdf
-
2
-
3